Abstract:Pre-eclampsia affects 2-8 % of pregnancies worldwide. It is a syndrome of new onset hypertension and proteinuria in the second half of pregnancy, typically characterized by endothelial dysfunction and systemic activation of an infl ammatory response. Both maternal and fetal complications of pre-eclampsia are potentially fatal or detrimental to long-term health. This chapter considers the role of hemostasis in the pathophysiology of preeclampsia and potential future therapeutic options.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.